The role of luteinizing hormone in folliculogenesis and ovulation induction

Fertility and Sterility

Volumn 71, Issue 3, 1999, Pages 405-414

  Filicori, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Estrogens, oocyte; Folliculogenesis; FSH; Gonadotropins; LH; Menotropins; Ovulation induction

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE;

ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; FEMALE; FERTILIZATION; FOLLITROPIN RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME;

EID: 0032957935     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00482-8     Document Type: Review

References (88)

1. Adashi E.Y. The ovarian follicular apparatus. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive endocrinology, surgery, and technology. 1996;17-40 Lippincott-Raven, Philadelphia.
2. Gulyas B.J., Hodgen G.D., Tullner W.W., Ross G.T. Effects of fetal or maternal hypophysectomy on endocrine organs and body weight in infant rhesus monkeys (Macaca mulatta) with particular emphasis on oogenesis . Biol Reprod. 16:1977;216-227.
3. Gougeon A. Dynamics of follicular growth in the human a model from preliminary results . Hum Reprod. 1:1986;81-87.
4. Gougeon A., Chainy G.B. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil. 81:1987;433-442.
5. Ryan K.J., Petro Z. Steroid biosynthesis by human ovarian granulosa and thecal cells. J Clin Endocrinol Metab. 26:1966;46-52.
6. Ryan K.J., Petro Z., Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and thecal cells. J Clin Endocrinol Metab. 28:1968;355-358.
7. Winter J.S., Faiman C., Hobson W.C., Prasad A.V., Reyes F.I. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J Clin Endocrinol Metab. 40:1975;545-551.
8. Louvet J.P., Harman S.M., Schrieber J.R., Ross G.T. Evidence of a role of androgens in follicular maturation. Endocrinology. 97:1975;366-372.
9. Ross G.T. Gonadotropins and preantral follicular maturation in women. Fertil Steril. 25:1974;522-543.
10. Hild-Petito S., West N.B., Brenner R.M., Stouffer R.L. Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biol Reprod. 44:1991;561-568.
11. Andersen C.Y. Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab. 77:1993;1227-1234.
12. Filicori M., Flamigni C., Cognigni G.E., Falbo A., Arnone R., Capelli M., et al. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril. 65:1996;387-393.
13. Erickson G.F., Wang C., Hsueh A.J. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature. 279:1979;336-338.
14. Lawrence T.S., Dekel N., Beers W.H. Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells a comparative study . Endocrinology. 106:1980;1114-1118.
15. Espey L.L. Ovarian proteolytic enzymes and ovulation. Biol Reprod. 10:1974;216-235.
16. Brailly S., Gougeon A., Milgrom E., Bomsel H.O., Papiernik E. Androgens and progestins in the human ovarian follicle differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles . J Clin Endocrinol Metab. 53:1981;128-134.
17. Karnitis V.J., Townson D.H., Friedman C.I., Danforth D.R. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys examining the role of luteinizing hormone in follicular development and steroidogenesis . J Clin Endocrinol Metab. 79:1994;91-97.
18. Fritz M.A., Speroff L. The endocrinology of the menstrual cycle the interaction of folliculogenesis and neuroendocrine mechanisms . Fertil Steril. 38:1982;509-529.
19. Zhuang L.Z., Adashi E.Y., Hsuch A.J. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology. 110:1982;2219-2221.
20. Artini P.G., Battaglia C., D'Ambrogio G., Barreca A., Droghini F., Volpe A., et al. Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum Reprod. 9:1994;902-906.
21. Shoham Z., Schachter M. Estrogen biosynthesis - regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. Fertil Steril. 65:1996;687-701.
22. Botero-Ruiz W., Laufer N., DeCherney A.H., Polan M.L., Haseltine F.P., Behrman H.R. The relationship between follicular fluid steroid concentration and successful fertilization of human oocytes in vitro. Fertil Steril. 41:1984;820-826.
23. Kreiner D., Liu H.C., Itskovitz J., Veeck L., Rosenwaks Z. Follicular fluid estradiol and progesterone are markers of preovulatory oocyte quality. Fertil Steril. 48:1987;991-994.
24. Bertrand E., Van-den-Bergh M., Englert Y. Clinical parameters influencing human zona pellucida thickness. Fertil Steril. 66:1996;408-411.
25. Wu T.C., Wang L., Wan Y.J. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril. 59:1993;54-59.
26. Yoshimura Y., Wallach E.E. Studies of the mechanism(s) of mammalian ovulation. Fertil Steril. 47:1987;22-34.
27. Yoshimura Y., Hosoi Y., Atlas S.J., Wallach E.E. Effect of clomiphene citrate on in vitro ovulated ova. Fertil Steril. 45:1986;800-804.
28. Yoshimura Y., Hosoi Y., Atlas S.J., Bongiovanni A.M., Santulli R., Wallach E.E. The effect of ovarian steroidogenesis on ovulation and fertilizability in the in vitro perfused rabbit ovary. Biol Reprod. 35:1986;943-948.
29. Yoshimura Y., Hosoi Y., Bongiovanni A.M., Santulli R., Atlas S.J., Wallach E.E. Are ovarian steroids required for ovum maturation and fertilization? Effects of cyanoketone on the in vitro perfused rabbit ovary. Endocrinology. 120:1987;2555-2561.
30. Zelinski-Wooten M.B., Hess D.L., Baughman W.L., Molskness T.A., Wolf D.P., Stouffer R.L. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys effects on follicle development, oocyte maturation, and subsequent luteal function . J Clin Endocrinol Metab. 76:1993;988-995.
31. Zelinski-Wooten M.B., Hess D.L., Wolf D.P., Stouffer R.L. Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertil Steril. 61:1994;1147-1155.
32. Hibbert M.L., Stouffer R.L., Wolf D.P., Zelinski-Wooten M.B. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci USA. 93:1996;1897-1901.
33. Zelinski-Wooten M.B., Hutchison J.S., Hess D.L., Wolf D.P., Stouffer R.L. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum Reprod. 10:1995;1658-1666.
34. Weston A.M., Zelinski-Wooten M.B., Hutchison J.S., Stouffer R.L., Wolf D.P. Developmental potential of embryos produced by in vitro fertilization from gonadotrophin-releasing hormone antagonist-treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod. 11:1996;608-613.
35. Tesarik J., Mendoza C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes relationship to oocyte developmental potential . J Clin Endocrinol Metab. 80:1995;1438-1443.
36. Palermo G.D., Alikani M., Bertoli M., Colombero L.T., Moy F., Cohen J., et al. Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intracytoplasmic sperm injection. Hum Reprod. 11:1996;172-176.
37. Rabinovici J., Blankstein J., Goldman B., Rudak E., Dor Y., Pariente C., et al. In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab. 68:1989;693-697.
38. Pellicer A., Miro F., Sampaio M., Gomez E., Bonilla M.F. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril. 55:1991;970-975.
39. Waldstreicher J., Santoro N.F., Hall J.E., Filicori M., Crowley W.F.J. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease indirect evidence for partial gonadotroph desensitization . J Clin Endocrinol Metab. 66:1988;165-172.
40. Shoham Z., Jacobs H.S., Insler V. Luteinizing hormone its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase . Fertil Steril. 59:1993;1153-1161.
41. Uilenbroek J.T., Woutersen P.J., Van-der-Schoot P. Atresia of preovulatory follicles gonadotropin binding and steroidogenic activity . Biol Reprod. 23:1980;219-229.
42. Anderson R.E., Cragun J.M., Chang R.J., Stanczyk F.Z., Lobo R.A. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome. Fertil Steril. 52:1989;216-220.
43. Tanbo T., Dale P.O., Kjekshus E., Haug E., Abyholm T. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril. 53:1990;798-803.
44. Sagle M.A., Hamilton F.D., Kiddy D.S., Franks S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril. 55:1991;56-60.
45. Filicori M., Campaniello E., Michelacci L., Pareschi A., Ferrari P., Bolelli G., et al. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. J Clin Endocrinol Metab. 66:1988;327-333.
46. Filicori M. Clinical review 81 gonadotropin-releasing hormone analogs in ovulation induction: current status and perspectives . J Clin Endocrinol Metab. 81:1996;2413-2416.
47. Diedrich K., Diedrich C., Santos E., Zoll C., al Hasani S., Reissmann T., et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 9:1994;788-791.
48. Yen S.C., Llerena L.A., Pearson O.H., Littell A.S. Disappearance rates of endogenous follicle-stimulating hormone in serum following surgical hypophysectomy in man. J Clin Endocrinol Metab. 30:1970;325-329.
49. Yen S.S., Llerena O., Little B., Pearson O.H. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. J Clin Endocrinol Metab. 28:1968;1763-1767.
50. Mannaerts B., de Leeuw R., Geelen J., Van Ravestein A., Van Wezenbeek P., Schuurs A., et al. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology. 129:1991;2623-2630.
51. Fleming R., Chung C.C., Yates R.W., Coutts J.R. Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod. 11:1996;1854-1858.
52. Lloyd F., Herbert M., Fenwick J., Griffiths T., Murdoch A., Fleming R. Prospective determination of the effects of profound LH suppression on follicular activity and oocyte and embryo function in cycles stimulated with purified FSH. Hum Reprod. 12:(Suppl 1):1997;101-102.
53. Schoot D.C., Harlin J., Shoham Z., Mannaerts B.M., Lahlou N., Bouchard P., et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum Reprod. 9:1994;1237-1242.
54. Couzinet B., Lestrat N., Brailly S., Forest M., Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 66:1988;552-556.
55. Shoham Z., Balen A., Patel A., Jacobs H.S. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril. 56:1991;1048-1053.
56. Schoot D.C., Coelingh B.H., Mannaerts B.M., Lamberts S.W., Bouchard P., Fauser B.C. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab. 74:1992;1471-1473.
57. Balasch J., Miro F., Burzaco I., Casamitjana R., Civico S., Ballesca J.L., et al. The role of luteinizing hormone in human follicle development and oocyte fertility evidence from in vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone . Hum Reprod. 10:1995;1678-1683.
58. Larsen T., Larsen J.F., Schioler V., Bostofte E., Felding C. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome. Fertil Steril. 53:1990;426-431.
59. Venturoli S., Paradisi R., Fabbri R., Magrini O., Porcu E., Flamigni C. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary. Obstet Gynecol. 63:1984;6-11.
60. Venturoli S., Paradisi R., Fabbri R., Porcu E., Orsini L.F., Flamigni C. Induction of ovulation in polycystic ovary human menopausal gonadotropin or human urinary follicle stimulating hormone? Int J Fertil. 32:1987;66-70.
61. Check J.H., Fine W. Similar pregnancy and spontaneous abortion rates after treatment with low-dose human menopausal gonadotropin versus pure follicle stimulating hormone in women with luteal phase defects. Clin Exp Obstet Gynecol. 24:1997;5-7.
62. Venturoli S., Orsini L.F., Paradisi R., Fabbri R., Porcu E., Magrini O., et al. Human urinary follicle-stimulating hormone and human menopausal gonadotropin in induction of multiple follicle growth and ovulation. Fertil Steril. 45:1986;30-35.
63. Scoccia B., Blumenthal P., Wagner C., Prins G., Scommegna A., Marut E.L. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program. Fertil Steril. 48:1987;446-449.
64. Bentick B., Shaw R.W., Iffland C.A., Burford G., Bernard A. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with buserelin for superovulation and in vitro fertilization. Fertil Steril. 50:1988;79-84.
65. Lavy G., Pellicer A., Diamond M.P., DeCherney A.H. Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone a randomized prospective study . Fertil Steril. 50:1988;74-78.
66. Edelstein M.C., Brzyski R.G., Jones G.S., Simonetti S., Muasher S.J. Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression. [see comments] Fertil Steril. 53:1990;103-106.
67. Check J.H., O'Shaughnessy A., Nazari A., Hoover L. Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization. Gynecol Obstet Invest. 40:1995;117-119.
68. Torok A., Hamori M., Tinneberg H.R., Cledon P., Gagsteiger F., Hanf V. Comparison of the effects of HMG or pure FSH stimulation during suppression with an LHRH agonist analogue. Hum Reprod. 6:1991;922-924.
69. Devroey P., Tjandraprawira K., Mannaerts B., Coelingh B.H., Smitz J., Bonduelle M., et al. A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in vitro fertilization. Hum Reprod. 10:1995;332-337.
70. Balasch J., Fabregues F., Creus M., Moreno V., Puerto B., Penarrubia J., et al. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in vitro fertilization. Hum Reprod. 11:1996;2400-2404.
71. Imthurn B., Macas E., Rosselli M., Keller P.J. Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum Reprod. 11:1996;2387-2391.
72. Fried G., Harlin J., Csemiczky G., Wramsby H. Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG. Hum Reprod. 11:1996;474-477.
73. Out H.J., Driessen S.G., Mannaerts B.M., Coelingh B.H. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril. 68:1997;138-142.
74. Rekha P., Mowat L., Jamieson M.E., Yates R.W.S., Fleming R. Effect of profound suppression of luteinizing hormone during treatment with gonadotropin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos. Hum Reprod. 13:1998;696-698.
75. Polan M.L., Daniele A., Russell J.B., DeCherney A.H. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab. 63:1986;1284-1291.
76. Russell J.B., Polan M.L., DeCherney A.H. The use of pure follicle-stimulating hormone for ovulation induction in normal ovulatory women in an in vitro fertilization program. Fertil Steril. 45:1986;829-833.
77. Daya S., Gunby J., Hughes E.G., Collins J.A., Sagle M.A. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in vitro fertilization. Hum Reprod. 10:1995;1392-1396.
78. Daya S., Gunby J., Hughes E.G., Collins J.A., Sagle M.A. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles a meta-analysis . Fertil Steril. 64:1995;347-354.
79. Mercan R., Mayer J.F., Walker D., Jones S., Oehninger S., Toner J.P., et al. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. Hum Reprod. 12:1997;1886-1889.
80. Soderstrom-Anttila V., Foudila T., Hovatta O. A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum Reprod. 11:1996;1864-1870.
81. Westergaard L.G., Erb K., Laursen S., Rasmussen P.E., Rex S. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod. 11:1996;1209-1213.
82. Gordon U.D., Gordon A.C., Bonnar J., Harrison R.F. A randomized prospective study of the effect of LH on follicular growth and development. Hum Reprod. 12:(Suppl 1):1997;52.
83. Gordon U.D., Gordon A.C., Bonnar J., Harrison R.F. Effect of differing doses of LH on oocyte maturation and fertilization. Hum Reprod. 12:(Suppl 1):1997;53-54.
84. Duijkers I.J., Klipping C., Mulders T.M.T., Out H.J., Coelingh B.H., Vemer H.M. Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations. Hum Reprod. 12:1997;2379-2384.
85. Martikainen H., Ronnberg L., Puistola U., Kirkinen P., Ruokonen A., Nikula H., et al. Comparison of the effects of follicle-stimulating hormone and human menopausal gonadotropin on peripheral serum and follicular fluid hormones during ovarian stimulation. Fertil Steril. 46:1986;317-320.
86. Howles C.M., Loumaye E., Giroud D., Luyet G. Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF a multicentre European phase III study . Hum Reprod. 9:1994;424-430.
87. Loumaye E., Engrand P., Howles C.M., O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril. 67:1997;889-899.
88. A double-blind, randomised, dose-finding study to assess the efficacy of the GnRH antagonist Ganirelix (Org 37462) to prevent premature LH surges in women undergoing controlled ovarian hyperstimulation with recombinant FSH (Puregon). Hum Reprod. 13:1998;3023-3031.